Brean Murray Carret & Co. Starts China Gerui Advanced Materials (CHOP) at Buy
CHOP Hot Sheet
Rating Summary:3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Brean Murray Carret & Co. initiates coverage on China Gerui Advanced Materials Group Ltd (NASDAQ: CHOP) with a Buy. PT $6.00.
Brean analyst says, "China Gerui is a leading player of converting hot-rolled steel into high-precision, ultra-thin, high-strength and high-margin, customized, cold-rolled steel products. We think the company is well positioned to outperform its peers given its market-leader status, expanding capacity, nationwide customer base, and the potential for increased operating leverage. We expect CHOP’s FY12 revenue and EPS to grow 26% YoY, to reach $434M and $1.46, respectively."
For an analyst ratings summary and ratings history on China Gerui Advanced Materials Group Ltd click here. For more ratings news on China Gerui Advanced Materials Group Ltd click here.
Shares of China Gerui Advanced Materials Group Ltd closed at $3.78 yesterday, with a 52 week range of $1.87-$6.15.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
Brean analyst says, "China Gerui is a leading player of converting hot-rolled steel into high-precision, ultra-thin, high-strength and high-margin, customized, cold-rolled steel products. We think the company is well positioned to outperform its peers given its market-leader status, expanding capacity, nationwide customer base, and the potential for increased operating leverage. We expect CHOP’s FY12 revenue and EPS to grow 26% YoY, to reach $434M and $1.46, respectively."
For an analyst ratings summary and ratings history on China Gerui Advanced Materials Group Ltd click here. For more ratings news on China Gerui Advanced Materials Group Ltd click here.
Shares of China Gerui Advanced Materials Group Ltd closed at $3.78 yesterday, with a 52 week range of $1.87-$6.15.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- Roth Capital Starts Nektar Therapeutics (NKTR) at Buy
- China Gerui AMG (CHOP) Misses Q1 EPS by 1c; Reaffirms Outlook
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
